Communiqués Victrex plc

Actions

VCT

GB0009292243

Chimie de spécialité

Marché Fermé - London S.E. 17:35:04 19/08/2026			Varia. 5j.	Varia. 1 janv.
834,00 ^GBX	+1,58 %		+2,08 %	+27,33 %

15:13	Victrex plc : Singer Capital Markets toujours à l'achat	ZM
24/07	Victrex : le directeur financier quittera ses fonctions fin juillet	MT

Communiqués

27/07	From Material Innovation to a More Sustainable Future: Victrex Recognised by the FTSE Green Economy Mark	PU
13/05	Victrex : Interim results 2026	PU
11/05	Victrex : Interim Results 2026 (Victrex plc interim results presentation final 110526)	PU
18/02	(function(){var a=document.querySelector(".down-arrow"),b=a.querySelectorAll("style"),c=function(d){b.forEach(function(f){var g=f.textContent;g&&(f.textContent=g.replace(/transform-box:[^;rn]*/gi,"transform-box: "+d))})};c("initial"),window.requestAnimationFrame(function(){return c("fill-box")})})(); (ESG Comms Pack Jan 26 1)	PU
06/02	Victrex : Resolutions passed as Special Business at AGM	PU
23/12	(function(){var a=document.querySelector(".down-arrow"),b=a.querySelectorAll("style"),c=function(d){b.forEach(function(f){var g=f.textContent;g&&(f.textContent=g.replace(/transform-box:[^;rn]*/gi,"transform-box: "+d))})};c("initial"),window.requestAnimationFrame(function(){return c("fill-box")})})();Victrex PLC Sustainability Report (Victrex plc Sustainability Report 2025)	PU
22/12	Victrex : Annual Report 2025	PU
18/12	Victrex : Full year results presentation 2025 (Victrex plc FY results presentation 2025 FINAL 021225 1)	PU
18/12	Victrex : Capital markets event – Leeds (Medical) (Victrex Medical Investor Leeds visit Oct 2025 v2)	PU
18/12	Victrex : Investor Overview (Victrex investor overview Dec 2025)	PU
02/12	Victrex : Preliminary results announcement 2025	PU
02/12	Victrex : 2025 Full year results presentation (Victrex plc FY results presentation 2025 FINAL 021225)	PU
11/07/25	Victrex : Investor Overview (Victrex investor overview July 2025)	PU
20/06/25	Victrex : Sustainability & ESG (ESG Comms Pack 20 Jun Pubished)	PU
20/06/25	(function(){var a=document.querySelector(".down-arrow"),b=a.querySelectorAll("style"),c=function(d){b.forEach(function(f){var g=f.textContent;g&&(f.textContent=g.replace(/transform-box:[^;rn]*/gi,"transform-box: "+d))})};c("initial"),window.requestAnimationFrame(function(){return c("fill-box")})})(); (ESG Comms Pack 20 Jun Pubished)	PU
19/06/25	Victrex : First PEEK-OPTIMA™ Cases Performed in US IDE Study with Maxx Orthopedics’ Freedom® Total Knee System	PU
21/05/25	Victrex : Interim results 2025	PU
12/05/25	Victrex : Interim Results 2025 (Victrex FY25 interim results presentation FINAL)	PU
07/02/25	Victrex : Resolutions passed as Special Business at AGM	PU
01/12/24	Victrex : Statement with China Distributors Details	PU
25/09/24	Victrex : Nvision Biomedical Technologies™ Secures FDA Clearance for First 3D Printed Porous PEEK Interbody System made with Invibio PEEK OPTIMA™	PU
18/09/24	Victrex : Group investor visit September 2024	PU
06/06/24	Victrex : Interim Results 2024	PU
11/03/24	Victrex : US & Canada investor roadshow update	PU
12/06/23	Invibio, Part of Victrex plc, Announces New Collaboration With Paragon Medical to Support Scale Up of PEEK Based Trauma Devices	AQ